Lazard
LAZ
35.82
-0.54
-1.49%
Lazard
US · LAZ
#2381 by market cap
Listed 1970
35.82
-0.54
-1.49%
Live - 5344 symbols - heartbeat 476s ago
· 2026-10-07 20:02
After-hours
35.21
-1.70%
- Market cap
- 3.49B
- P/E (TTM)i
- 17.65
- P/Bi
- 3.82
- EPSi
- 2.17
- Div yieldi
- 5.58%
- 52W posi
- 5%
Reader sentiment
Are you bullish or bearish on LAZ?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.31, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.48% YoY
Margins
- Gross margin
- 33.75%
- Operating margin
- 11.97%
- Net margin
- 7.34%
Key ratios & quality
- Altman Z-Scorei
- 2.31
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.88B | 2.67B | 2.65B | 3.27B | 2.86B | 2.59B | 3.14B | 3.19B |
| Gross profit | 1.36B | 1.09B | 1.09B | 1.37B | 1.17B | 605.13M | 1.08B | 1.06B |
| Selling & admin expenses | 424.06M | 424.08M | 339.48M | 379.00M | 384.87M | 430.66M | 426.66M | 461.24M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 710.22M | 476.51M | 577.11M | 799.07M | 568.91M | -44.31M | 420.94M | 376.73M |
| Pretax profit | 680.77M | 392.70M | 502.14M | 723.85M | 516.85M | -79.96M | 386.47M | 327.60M |
| Tax | 148.32M | 94.98M | 99.45M | 181.30M | 124.37M | -22.65M | 99.76M | 76.58M |
| Net profit | 532.45M | 297.72M | 402.69M | 542.55M | 392.48M | -57.31M | 286.71M | 251.02M |
| Basic EPS | 4 | 3 | 4 | 5 | 4 | -1 | 3 | 2 |
| Diluted EPS | 4.06 | 2.44 | 3.54 | 4.63 | 3.51 | -0.90 | 2.68 | 2.17 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 669.16M | 817.16M | 770.76M | 929.38M | 779.40M | 830.20M |
| Gross profit | 227.23M | 288.75M | 264.89M | 281.72M | 279.69M | 260.54M |
| Selling & admin expenses | 108.53M | 117.94M | 111.33M | 123.44M | 114.28M | 139.15M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 64.09M | 105.04M | 109.96M | 97.65M | 104.58M | 52.88M |
| Pretax profit | 54.64M | 93.08M | 94.93M | 84.95M | 89.57M | 37.60M |
| Tax | -7.35M | 31.76M | 21.43M | 30.74M | -10.99M | 23.87M |
| Net profit | 61.99M | 61.32M | 73.50M | 54.21M | 100.56M | 13.73M |
| Basic EPS | 1 | 1 | 1 | 0 | 1 | 0 |
| Diluted EPS | 0.56 | 0.52 | 0.65 | 0.45 | 0.91 | 0.03 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.16B | 3.30B | 3.54B | 4.52B | 3.58B | 2.29B | 2.62B | 2.78B |
| Cash & ST investments | 2.25B | 2.41B | 2.52B | 2.81B | 2.01B | 1.19B | 1.58B | 1.64B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 5.00B | 5.64B | 5.97B | 7.15B | 5.85B | 4.64B | 4.79B | 4.94B |
| Total current liabilities | 1.80B | 1.91B | 1.83B | 2.15B | 1.56B | 1.03B | 896.79M | 886.39M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 1.43B | 1.68B | 1.68B | 1.69B | 1.69B | 1.69B | 1.69B | 1.69B |
| Total liabilities | 4,027,148,000.00 | 4,958,007,000.00 | 4,972,428,000.00 | 5,494,217,000.00 | 4,593,691,000.00 | 4,065,919,000.00 | 4,029,210,000.00 | 3,951,604,000.00 |
| Total equity | 970.09M | 681.57M | 999.43M | 1.65B | 1.26B | 569.86M | 764.78M | 989.13M |
| Retained earnings | 1.20B | 1.19B | 1.30B | 1.56B | 1.68B | 1.40B | 1.47B | 1.49B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.89B | 2.00B | 2.20B | 2.78B | 2.01B | 2.07B |
| Cash & ST investments | 1.17B | 1.22B | 1.39B | 1.64B | 1.23B | 1.30B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 4.23B | 4.49B | 4.63B | 4.94B | 4.24B | 4.36B |
| Total current liabilities | 411.21M | 476.15M | 402.58M | 886.39M | 357.71M | 362.91M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 1.69B | 1.69B | 1.69B | 1.69B | 1.69B | 1.69B |
| Total liabilities | 3,499,703,000.00 | 3,623,324,000.00 | 3,676,776,000.00 | 3,951,604,000.00 | 3,286,767,000.00 | 3,348,843,000.00 |
| Total equity | 732.36M | 870.06M | 957.14M | 989.13M | 953.88M | 1.02B |
| Retained earnings | 1.48B | 1.48B | 1.49B | 1.49B | 1.56B | 1.51B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 699.04M | 677.95M | 575.93M | 866.08M | 833.98M | 164.66M | 742.83M | 519.33M |
| Depreciation & amortization | 18.21M | 54.98M | 36.89M | 38.38M | 42.34M | 42.85M | 36.28M | 34.19M |
| Free cash flow | 649.45M | 635.20M | 511.65M | 826.38M | 784.47M | 136.37M | 697.33M | 487.38M |
| Dividends paid | -359.64M | -254.92M | -196.60M | -195.94M | -181.88M | -173.08M | -179.02M | -186.58M |
| Stock buybacks / issuance | -552.87M | -494.69M | -95.23M | 168.85M | -691.71M | -102.05M | -59.50M | -91.01M |
| Ending cash balance | 2.29B | 2.46B | 2.57B | 3.43B | 2.64B | 1.22B | 1.61B | 1.67B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -217.53M | 49.68M | 287.47M | 399.70M | -219.27M | 203.40M |
| Depreciation & amortization | 8.44M | 8.63M | 8.48M | 8.64M | 7.82M | 7.37M |
| Free cash flow | -231.35M | 37.99M | 284.62M | 396.12M | -221.45M | 199.48M |
| Dividends paid | -44.95M | -47.07M | -47.18M | -47.38M | -46.95M | -49.25M |
| Stock buybacks / issuance | -36.17M | -3.76M | -1.08M | -50.00M | -1.69M | -50.00M |
| Ending cash balance | 1.21B | 1.25B | 1.42B | 1.67B | 1.23B | 1.30B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 49.81 | 37.08 | 51.89 | 55.05 | 45.93 | -16.31 | 51.51 | 30.59 |
| ROA %i | 10.62 | 5.32 | 6.80 | 7.92 | 5.41 | -1.52 | 5.79 | 4.74 |
| ROIC %i | 23.73 | 12.56 | 14.83 | 17.95 | 13.11 | -2.03 | 11.00 | 9.14 |
| 5-year avg ROE %i | 53.23 | 47.16 | 38.00 | 42.93 | 47.95 | 34.73 | 37.62 | 33.36 |
| EBIT margin %i | 25.74 | 17.84 | 22.07 | 24.62 | 21.18 | -0.09 | 15.38 | 13.19 |
| FCF / sales %i | 22.62 | 23.96 | 19.37 | 25.29 | 27.76 | 5.35 | 22.59 | 15.48 |
| Current ratioi | 1.75 | 1.73 | 1.93 | 2.10 | 2.29 | 2.22 | 2.92 | 3.14 |
| Quick ratioi | 1.65 | 1.64 | 1.81 | 1.70 | 1.75 | 1.96 | 2.65 | 2.92 |
| Debt / assetsi | 28.70 | 41.21 | 38.34 | 31.31 | 37.61 | 46.93 | 45.74 | 43.99 |
| LT debt / equityi | 156.43 | 380.97 | 251.13 | 229.46 | 395.61 | 513.36 | 344.61 | 248.75 |
| Interest coveragei | 12.64 | 5.90 | 7.23 | 9.96 | 7.34 | -0.03 | 5.39 | 4.74 |
| Revenue CAGR (3Y) %i | 6.17 | 3.69 | -0.62 | 4.41 | 2.15 | -1.15 | -1.89 | 3.67 |
| Net income CAGR (3Y) %i | -18.85 | -9.59 | 16.65 | 0.06 | 7.66 | -- | -19.07 | -12.83 |
| FCF CAGR (3Y) %i | -8.96 | 2.27 | -20.06 | 8.36 | 7.29 | -35.65 | -5.50 | -14.67 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 59.68 | 50.41 | 36.41 | 30.59 | 36.37 | 26.68 |
| ROA %i | 6.74 | 6.71 | 5.65 | 4.74 | 6.37 | 4.99 |
| ROIC %i | 11.80 | 11.44 | 9.99 | 9.14 | 10.74 | 8.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 15.99 | 16.32 | 14.31 | 13.19 | 13.85 | 12.14 |
| FCF / sales %i | 18.94 | 13.97 | 14.39 | 15.48 | 15.24 | 20.10 |
| Current ratioi | 4.60 | 4.21 | 5.46 | 3.14 | 5.61 | 5.70 |
| Quick ratioi | 4.51 | 4.14 | 5.38 | 2.92 | 5.60 | 5.68 |
| Debt / assetsi | 51.79 | 49.11 | 47.43 | 43.99 | 50.97 | 49.33 |
| LT debt / equityi | 363.45 | 297.57 | 261.20 | 248.75 | 245.25 | 235.48 |
| Interest coveragei | 5.37 | 5.78 | 5.01 | 4.74 | 5.06 | 4.39 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Financial Advisory is the largest reported line at 54.22% of revenue, across 4 reported segments.
- Asset Management follows at 42.28%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Financial Advisory54.22%
Asset Management42.28%
Interest Expense2.71%
Corporate0.78%
Quote time 2026-10-07 20:02:22 · For reference only, not investment advice and not tailored to your situation.